Phase II Study of Paclitaxel in Patients With Soft Tissue Sarcomas

Shreyaskumar R. Patel; Kaye A. Linke; M. Andrew Burgess; Nicholas E. Papadopoulos; Carl Plager; Jan Jenkins; Robert Benjamin

doi:10.1080/13577149778362

Sarcoma (Jan 1997)

Phase II Study of Paclitaxel in Patients With Soft Tissue Sarcomas

Shreyaskumar R. Patel,
Kaye A. Linke,
M. Andrew Burgess,
Nicholas E. Papadopoulos,
Carl Plager,
Jan Jenkins,
Robert Benjamin

Affiliations

Shreyaskumar R. Patel: Department of Melanoma/Sarcoma Medical Oncology, MD Anderson Cancer Center, University of Texas, PO Box 77, 1515 Holcombe Blvd, Houston, TX 77030, USA
Kaye A. Linke: Department of Melanoma/Sarcoma Medical Oncology, MD Anderson Cancer Center, University of Texas, PO Box 77, 1515 Holcombe Blvd, Houston, TX 77030, USA
M. Andrew Burgess: Department of Melanoma/Sarcoma Medical Oncology, MD Anderson Cancer Center, University of Texas, PO Box 77, 1515 Holcombe Blvd, Houston, TX 77030, USA
Nicholas E. Papadopoulos: Department of Melanoma/Sarcoma Medical Oncology, MD Anderson Cancer Center, University of Texas, PO Box 77, 1515 Holcombe Blvd, Houston, TX 77030, USA
Carl Plager: Department of Melanoma/Sarcoma Medical Oncology, MD Anderson Cancer Center, University of Texas, PO Box 77, 1515 Holcombe Blvd, Houston, TX 77030, USA
Jan Jenkins: Department of Melanoma/Sarcoma Medical Oncology, MD Anderson Cancer Center, University of Texas, PO Box 77, 1515 Holcombe Blvd, Houston, TX 77030, USA
Robert Benjamin: Department of Melanoma/Sarcoma Medical Oncology, MD Anderson Cancer Center, University of Texas, PO Box 77, 1515 Holcombe Blvd, Houston, TX 77030, USA

DOI: https://doi.org/10.1080/13577149778362
Journal volume & issue: Vol. 1, no. 2
pp. 95 – 97

Abstract

Read online

Purpose. Patients with soft tissue sarcoma (STS) who have previously received standard chemotherapy including adriamycin (doxorubicin), ifosfamide, cyclophosphamide and DTIC (dacarbazine) have very limited therapeutic options. It is important to identify new drugs with some activity in this disease and we therefore undertook this trial to determine the antitumor activity of paclitaxel (Taxol).

Published in Sarcoma

ISSN: 1357-714X (Print); 1369-1643 (Online)
Publisher: Hindawi Limited
Country of publisher: United Kingdom
LCC subjects: Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens
Website: https://onlinelibrary.wiley.com/journal/5805

About the journal